Medical Need of OAC Reversal

NCT03254147 · clinicaltrials.gov ↗

COMPLETED

Status

53969

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: warfarin
DRUG: dabigatran
DRUG: Apixaban
DRUG: Edoxaban
DRUG: Rivaroxaban

Sponsor

Boehringer Ingelheim